The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Primary Central Nervous System Vasculitis (PCNSV)

Idiopathic Inflammatory Cerebral Vasculopathy with Diagnostic and Therapeutic Challenges

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Primary Central Nervous System Vasculitis (PCNSV)?

Primary central nervous system vasculitis (PCNSV) is an idiopathic inflammatory vasculopathy limited to brain, spinal cord, and leptomeningeal vessels with annual incidence approximately 2.4 per million.

Pathology shows granulomatous (most common), lymphocytic, or necrotizing inflammation of small-to-medium arteries and arterioles, sometimes with associated amyloid-beta deposition (Aβ-related angiitis variant).

Calabrese-Mallek criteria require: clinical neurologic deficit, biopsy or angiographic evidence of vasculitis, and exclusion of systemic vasculitis, infection, malignancy, or other mimics.

Major diagnostic challenge is differentiation from reversible cerebral vasoconstriction syndrome (RCVS), atherosclerotic disease, infectious vasculitis, and intravascular lymphoma.

Symptoms

Insidious-onset headache (most common, 50–60%), often persistent and unresponsive to typical analgesics
Cognitive impairment and behavioral changes: confusion, memory loss, executive dysfunction (40–70%)
Focal neurological deficits: hemiparesis, aphasia, visual field defects from cortical or subcortical infarcts
Recurrent strokes or transient ischemic attacks in multiple vascular territories without typical risk factors
Seizures (focal or generalized) in 20–30% from cortical inflammation or infarcts
Spinal cord involvement: myelopathy with motor and sensory deficits (uncommon, 5–10%)
Subacute progression over weeks to months distinguishes from acute stroke or RCVS thunderclap headache

Risk Factors

Adults aged 40–60 years (median onset around 50 years), with slight male predominance
Aβ-related angiitis variant occurs in older patients (60–70 years) often with cognitive symptoms
No clear genetic predisposition or environmental triggers established
Differential considerations: connective tissue disease (SLE, RA), ANCA-associated vasculitis, infections (varicella zoster vasculopathy, syphilis, HIV, tuberculosis), drug-induced (cocaine, amphetamines), malignancy (intravascular lymphoma), atherosclerosis
Distinction from RCVS critical: RCVS features thunderclap headache, female predominance, vasoactive drug or postpartum trigger, and reversibility within 3 months

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Subacute or recurrent unexplained neurological symptoms in adults without typical stroke risk factors
  • Persistent headache with cognitive decline, focal deficits, or seizures
  • Multiple infarcts in different vascular territories on MRI without cardioembolic source or atherosclerosis
  • Suspected cerebral vasculitis on imaging requiring multidisciplinary evaluation
  • Established PCNSV with treatment failure, relapse, or immunosuppression-related complications

Treatment Methods

01
Comprehensive evaluation: brain MRI with contrast (multifocal infarcts, leptomeningeal enhancement, parenchymal lesions), MR angiography or catheter angiography (alternating stenoses and dilations, 'beading'), vessel-wall MRI (concentric mural enhancement)
02
Cerebrospinal fluid analysis: lymphocytic pleocytosis, elevated protein in 80–90%; rules out infection and malignancy
03
Brain and leptomeningeal biopsy: gold standard for diagnosis, particularly when angiography is normal or negative; sensitivity 50–75%, specificity high
04
Laboratory workup to exclude mimics: ANCA, ANA, complement, hepatitis serology, HIV, syphilis (RPR/VDRL), VZV PCR, blood cultures, complete blood count and chemistry, coagulation studies
05
Induction therapy: prednisolone 1 mg/kg/day (often after methylprednisolone pulse 1 g/day for 3–5 days) plus oral or IV cyclophosphamide (continuous oral 2 mg/kg/day or pulse IV 0.5–0.75 g/m² monthly) for 3–6 months
06
Maintenance therapy: azathioprine 2 mg/kg/day, mycophenolate mofetil 2–3 g/day, or methotrexate 15–25 mg/week for 12–24 months after remission
07
Refractory or relapsing cases: rituximab (1 g IV at days 0 and 14), tocilizumab, or intravenous immunoglobulin in selected cases; consider plasma exchange in severe presentation
08
Symptomatic management: antiplatelet or anticoagulant therapy (controversial; consider per stroke etiology), seizure control with antiepileptics, headache management, neurorehabilitation
09
Long-term monitoring: serial brain MRI every 3–6 months during induction, then annually; CSF reassessment if relapse suspected; mortality 10–20% over 5 years and significant morbidity in survivors

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.